Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > More positive data from AGN's phase 2 study!

View:

Post by waves1 on Aug 08, 2022 6:07pm

More positive data from AGN's phase 2 study!

"More positive data" from AGN's Phase 2 study: https://www.youtube.com/watch?v=-aSxBqqp4Vo&ab_channel=Proactive

In the topline data, Ifenprodil is much more effective at reducing cough with the geometric mean 24-hour cough counts being reduced by 32.0% at 4 weeks and 39.5% at 12 weeks. Plus, the geometric mean awake cough counts were reduced by 30.2% at 4 weeks and 37.4% at 12 weeks.

The statistical improvement and statistical significance with such a small study size is quite significant and is an optimistic sign for the IPF phase 2b study going forward.

Keep an eye out for the full data to be released later in August.

125